The nation of Zimbabwe has rejected a major US health deal valued at 367 million US dollars (272 million pounds) over five years because of the United States' demand for sensitive data.
This move was revealed after a official document dated December was disclosed, indicating that Head of State Emmerson Mnangagwa deemed the arrangement was "lopsided".
An official spokesperson later clarified that the US was requesting genetic material for scientific study and commercial purposes while was unwilling to share the resulting advantages from any future medical innovations.
"We must now begin the difficult and regrettable process of scaling back our health assistance in Zimbabwe," stated American envoy to Zimbabwe Pamela Tremont in a statement.
The US Embassy noted the United States had donated more than $1.9bn for health programmes to Zimbabwe during the past twenty years.
A medical body in Zimbabwe has urged continued negotiations to reach a deal acceptable to all parties so the nation's critical HIV programme can proceed.
Wider Background
This development comes after a comparable situation in neighbouring Kenya, where a court halted a similar health funding agreement after concerns were filed about the safety of citizens' medical information.
After returning to office last year, US President Donald Trump has drastically cut overseas assistance and shut down the US Agency for International Development (USAID).
The agency had managed aid for the US government, but Trump argued its spending was "wasteful" and his administration was pursuing direct bilateral agreements to enhance openness and accountability.
According to statements, Sixteen African countries have so far agreed to similar health pacts, representing more than $18.3bn in new funding.
Details of the Rejected Agreement
The money for Zimbabwe was intended to gone towards "tackling HIV/Aids, TB, malaria, healthcare for mothers and children, and preparing for epidemics".
"We believe this collaboration could have provided extraordinary advantages for the people of Zimbabwe, particularly the 1.2 million men, women and children currently receiving antiretroviral therapy via American-funded programmes," the Ambassador commented.
However, government spokesperson Nick Mangwana said the arrangement was "unfair".
"Our nation was requested to surrender its biological resources and data for a long time, with no equivalent promise of benefiting from any medical innovations – like new medicines or tests – that might result from that provided information," Mangwana explained.
"Put simply, our nation would provide the raw materials for scientific discovery without any certainty that the final treatments would be available to our people should a future disease outbreak arise."
Sovereignty and International Frameworks
He also pointed out that the US's withdrawal from the World Health Organization (WHO) and its push of one-on-one health agreements were upending frameworks previously set up through the international health agency.
Mangwana gave as an example its Pathogen Access and Benefit Sharing framework designed to deal with potential global health emergencies.
"This framework is intended to ensure that when a country provides its samples, the benefits – including medicines and cures – are distributed fairly, not monopolised exclusively by those with the funds to create them."
The government's concerns regarding the US deal "are not meant as opposition to America," he added.
"We encourage ongoing discussions with our American counterparts on how future co-operation might be structured in a manner that honours the independence and dignity of each country."
Health Experts Response
A leading public health body said it acknowledged the government's concerns, but recommended that negotiations must proceed given that a large portion of the nation's HIV programmes depended on external financing.
"In cases where technical issues arise, such as those involving information security or agreement terms, these can frequently be addressed via detailed discussion and negotiated safeguards," it said.
The situation underscores the continuing debate between receiving vital foreign assistance and safeguarding national sovereignty in an ever more interconnected world.